您好，欢迎来到国际肝病网！

其他专题：APASL|APASL2014 |APASL2013|APASL2012|APASL2011|APASL2010|APASL2009|国际肝病

现场快报

专题首页 » 现场快报

⇔ [APASL2011]Will you follow up the patients with small liver nodule in cirrhosis or persuade the patient to receive a liver biopsy? 2011-02-23
⇔ [APASL2011]What do you think of the triple therapy of hepatitis C in your clinical practice? 2011-02-23
⇔ [APASL2011]Which one you think is more important for the management of hepatits B， quantitative detection of HBsAg or HBeAg or HBV DNA ? 2011-02-23
⇔ [APASL2011]Do you think that biospy would be replaced by noninvasive test methods? 2011-02-23
⇔ [APASL2011]When drug resistant to HBV developed， how will you choose to manage the patients? Modificate your strategies of oral nucleoside / nucleotide analogues or try immunomodulatory drugs， like interferon. Why? 2011-02-23
⇔ [APASL2011]Early screening of HCC is very importmant for prognosis， What methods commonly used in your clinical practice: serum marker or imaging? 2011-02-23
⇔ [APASL2011]Will you use statin to treat your patients with NAFLD ? Why？ 2011-02-23
⇔ [APASL2011]Do you think quantitative detection of HBsAg is important in treating patients with chronic hepatitis B? 2011-02-23
⇔ [APASL2011] To treat gastric variceal bleeding， which is your choice，TIPS or Glue? Why? 2011-02-23

首页 1 尾页

专题标签

学术领域

扫描二维码，用手机看今日话题